Annual report pursuant to Section 13 and 15(d)

Concentration of Risk

Concentration of Risk

12 Months Ended

Nov. 30, 2018

Most of the Company’s products are sold to major drug and food chains merchandisers, and wholesale beauty-aids distributors throughout the United States and Canada.

During the fiscal years ended November 30, 2018 and 2017, certain customers each accounted for more than 5% of the Company’s net sales, as follows:



	For the Year Ended November 30,
Customer	2018		2017
Walmart	41.5	%	36.3	%
Walgreens	16.3	%	13.4	%
Target	10.4	%	6.9	%
CVS	7.3	%	*
Foreign Sales	8.8	%	12.4	%



*	less than 5%

The loss of any one of these customers could have a material adverse effect on the Company’s earnings and financial position.

During the fiscal years November 30, 2018 and 2017, certain products within the Company’s product lines accounted for more than 10% of the Company’s net sales as follows:



	For the Year Ended November 30,
Category	2018		2017
Skin Care	59.3	%	52.6	%
Oral Care	34.2	%	37.8	%